Veronica Rendo (Verónica Rendo)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Induced Pluripotent Stem Cells

Dna Damage Response

Acute Lymphoblastic Leukemia

Top Venues

NAR genomics and bioinformatics

Molecular & cellular oncology

Angewandte Chemie (International ed. in English)

Nature genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Henrik Gezelius, Anna Pia Enblad, Anders Lundmark, Martin Åberg, Kristin Blom, Jakob Rudfeldt, Amanda Raine, Arja H Harila-Saari, Veronica Rendo, Sergei Häyrynen, Claes Andersson, Jessica Nordlund
Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening. NAR genomics and bioinformatics 6 (1) (2024)
Henrik Gezelius, Anna Pia Enblad, Anders Lundmark, Martin Åberg, Kristin Blom, Jakob Rudfeldt, Amanda Raine, Arja H Harila-Saari, Veronica Rendo, Sergei Häyrynen, Claes Andersson, Jessica Nordlund
Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening. NAR genomics and bioinformatics 6 (1) (2024)
Veronica Rendo, Oana M Enache, Uri Ben-David
Adding to the CASeload: unwarranted p53 signaling induced by Cas9. Molecular & cellular oncology 7 (5) (2020)
Oana M Enache, Veronica Rendo, Mai Abdusamad, Daniel Lam, Desiree Davison, Sangita Pal, Naomi Currimjee, Julian Hess, Sasha Pantel, Anwesha Nag, Aaron R Thorner, John G Doench, Francisca Vazquez, Rameen Beroukhim, Todd R Golub, Uri Ben-David
Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nature genetics 52 (7) (2020)
Veronica Rendo, Ivaylo Stoimenov, Tobias Sjöblom
Targeting tumor vulnerabilities associated with loss of heterozygosity. Molecular & cellular oncology 7 (4) (2020)
Louis P Conway, Veronica Rendo, Mario S P Correia, Ingvar A Bergdahl, Tobias Sjöblom, Daniel Globisch
Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N-Acetyltransferase NAT2. Angewandte Chemie (International ed. in English) 59 (34) (2020)
Veronica Rendo, Ivaylo Stoimenov, André Mateus, Elin Sjöberg, Richard Svensson, Anna-Lena Gustavsson, Lars Johansson, Adrian Ng, Casey OʼBrien, Marios Giannakis, Per Artursson, Peter Nygren, Ian Cheong, Tobias Sjöblom
Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy. Nature communications 11 (1) (2020)